Regulus Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RGLS and other ETFs, options, and stocks.

About RGLS

Regulus Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of drugs targeting microRNAs. Its two lead product candidates, RG-012 and RGLS4326, are in clinical development. 

CEO
Joseph P. Hagan
CEOJoseph P. Hagan
Employees
26
Employees26
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2007
Founded2007
Employees
26
Employees26

RGLS Key Statistics

Market cap
26.91M
Market cap26.91M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
54.77K
Average volume54.77K
High today
$1.75
High today$1.75
Low today
$1.55
Low today$1.55
Open price
$1.58
Open price$1.58
Volume
161.65K
Volume161.65K
52 Week high
$3.70
52 Week high$3.70
52 Week low
$1.08
52 Week low$1.08

RGLS Earnings

-$1.00
-$0.67
-$0.33
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 9, After Hours
ActualExpected Mar 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.